Children and adults with these risk conditions are at increased risk of pneumococcal disease and would benefit from additional doses of pneumococcal vaccine.
Many children and adults with these risk conditions are eligible for funded doses of 13vPCV and 23vPPV under the National Immunisation Program (NIP). However, some people with risk conditions for whom the vaccine is recommended are not eligible to receive funded vaccine doses. This is because the incidence of pneumococcal disease for these risk conditions is not sufficiently high to be cost-effective given the cost of vaccine purchase and delivery.
Vaccine doses for people with the risk conditions in this list are funded under the NIP unless otherwise noted. See also Vaccination for people who are immunocompromised for more recommendations for people who are immunocompromised, including specific revaccination recommendations for haematopoietic stem cell transplant recipients.
|Risk conditions at increased risk of pneumococcal disease
a. Not funded under the NIP